BROOKE VINCENT: Open Payments
NPI 1457583874 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 14 payments from 6 companies in 2025. Trend: 2023 $1,734 · 2024 $484 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $146 |
| Saluda Medical Americas, Inc. | 3 | $82 |
| TerSera Therapeutics LLC | 1 | $35 |
| Virtus Pharmaceuticals LLC | 1 | $28 |
| Curonix LLC | 1 | $15 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: XTAMPZA, Evoke, Prialt, LEVORPHANOL TARTRATE, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, JOURNAVX.
Industry payments across LA — which companies pay providers there.
